DSpace About DSpace Software
 

Makerere University Research Repository >
College of Health Sciences >
School of Health Sciences >
Research Articles (Health-Sciences) >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/1304

Title: Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis
Authors: Nahid, Payam
Bliven, Erin E.
Kim, Elizabeth Y.
MacKenzie, William R.
Stout, Jason E.
Diem, Lois
Johnson, John L.
Gagneux, Sebastien
Hopewell, Philip C.
Kato-Maeda, Midori
the Tuberculosis Trials Consortium
Keywords: Mycobacterium tuberculosis
TB (Disease)
Tuberclosis
Lungs-Diseases
Issue Date: 2010
Publisher: PLoS ONE
Citation: Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, et al. (2010) Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS ONE 5(5)
Abstract: Abstract Recent studies suggest that M. tuberculosis lineage and host genetics interact to impact how active tuberculosis presents clinically. We determined the phylogenetic lineages of M. tuberculosis isolates from participants enrolled in the Tuberculosis Trials Consortium Study 28, conducted in Brazil, Canada, South Africa, Spain, Uganda and the United States, and secondarily explored the relationship between lineage, clinical presentation and response to treatment. Large sequence polymorphisms and single nucleotide polymorphisms were analyzed to determine lineage and sublineage of isolates. Of 306 isolates genotyped, 246 (80.4%) belonged to the Euro-American lineage, with sublineage 724 predominating at African sites (99/192, 51.5%), and the Euro-American strains other than 724 predominating at non-African sites (89/114, 78.1%). Uneven distribution of lineages across regions limited our ability to discern significant associations, nonetheless, in univariate analyses, Euro-American sublineage 724 was associated with more severe disease at baseline, and along with the East Asian lineage was associated with lower bacteriologic conversion after 8 weeks of treatment. Disease presentation and response to drug treatment varied by lineage, but these associations were no longer statistically significant after adjustment for other variables associated with week-8 culture status.
URI: http://hdl.handle.net/123456789/1304
Appears in Collections:Research Articles (Health-Sciences)

Files in This Item:

File Description SizeFormat
nahid-payam-chs-res.pdf152KbAdobe PDFView/Open

All items in DSpace are protected by copyright, with all rights reserved.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2005 MIT and Hewlett-Packard - Feedback